gip/glp-1 agonist Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

GLP-1R Agonist Therapy for Diabetes: Benefits and Potential Risks

Weight Watchers supports healthy habits

How effective physical activity in reducing liver steatosis and/or reversing liver fibrosis in children

[DOI] [PMC free article] [PubMed] [Google Scholar] 159.Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC

Beyond Diabetes and Obesity: Researchers are studying numerous additional indications that could expand the use of these medications beyond diabetes and obesity

Additionally, patients taking multiple medications should be evaluated for potential drug interactions or additive effects, particularly if they are also taking statins, which have well-established myopathic potential